RxLibra

Search Generic Medicine

Medicine Index

Search by generic name

Tag: Pancreatic Cancer

Generic Entrectinib

Entrectinib is a tropomyosin receptor tyrosine kinase (TRK) TRKA, TRKB, TRKC, proto-oncogene tyrosine-protein kinase ROS1, and anaplastic lymphoma kinase (ALK) inhibitor. Entrectinib is approved to treat: Non-small cell lung cancer that is ROS1 positive(ROS1+NSCLC). It is used in adults whose cancer has metastasized (spread to other parts of the body). . . . Read more

Generic Larotrectinib

Larotrectinib is an orally administered, small molecule, highly-selective, tropomyosin receptor kinase (TRK) inhibitor that was developed by Loxo Oncology in collaboration with Bayer AG as a treatment for adult and paediatric patients whose cancers harbour neurotrophic receptor tyrosine kinase (NTRK) gene fusions. In November 2018 larotrectinib received its first global . . . Read more

Generic Erlotinib

Erlotinib is a tyrosine kinase inhibitor (TKI) which is a type of cancer growth blocker. It blocks proteins on cancer cells that encourage the cancer to grow.These proteins are called epidermal growth factor receptors (EGFR). If you have a cancer that has these receptors you are EGFR positive. You have . . . Read more

Generic Olaparib

Olaparib is a small molecule inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib is approved to treat: Breast cancer that is HER2 negative, has certain germline mutations in the BRCA1 or BRCA2 gene, and has metastasized (spread to other parts of the . . . Read more